Adults suffering with acute and immediate attack of migraine now have a new treatment option with the approval of Ubrelvy (ubrogepant) by the U.S. Food and Drug Administration. Allergan USA, Inc.'s Ubrelvy tablets are approved to treat migraine with or without aura - a sensory phenomenon or visual disturbance, in adults. However, it is not indicated for the preventive treatment of migraine.
from RTT - Biotech https://ift.tt/2Mq5HGs
via IFTTT
No comments:
Post a Comment